A study of children undergoing milk allergy oral immunotherapy at a Montreal Hospital finds allergic reaction side effects are common,… Read more »
Author: Allergic Living
Viaskin Peanut Patch Back on the FDA Approval Track for Fall 2019
The manufacturer of the Viaskin Peanut patch has announced plans to resubmit its biologics license application (BLA) for the therapy… Read more »
Big Recall of Frozen Chicken Entrees Because of Undeclared Egg
Allergic Living advises consumers with egg allergy to be aware that the USDA has issued a major recall of almost… Read more »
Allergy Alert: Pita Chips, Cookies Recalled Due to Undeclared Allergens
The FDA has issued two recalls of chips and cookies product due to undeclared allergens. There has been one allergic… Read more »
Dairy and Other Recall for 2 Brands of Chicken Nuggets
Allergic Living advises consumers to be aware that the USDA has issued warnings about two chicken nugget recalls. 1. First,… Read more »
Aimmune Applies to Move Forward on Testing Novel Egg Allergy Treatment
Aimmune Therapeutics, the company behind the AR101 oral immunotherapy (OIT) treatment for peanut allergy, announced on Dec. 20, 2018 that… Read more »
EpiPen May Stick in Carrying Tube, Warns FDA
The FDA is warning that the labels on some EpiPen and EpiPen Jr auto-injectors, as well the generic versions of… Read more »
Experts’ Viewpoint on: Epinephrine Auto-Injector Needle Length and Dosing Debate
As board-certified allergists who are expert in the treatment of anaphylaxis, we wish to express serious concerns with the conclusions… Read more »
Xolair Gains “Breakthrough” Status to Be Developed as Food Allergy Treatment
The FDA has given its “breakthrough therapy designation” to omalizumab, known by the brand Xolair, to be developed as a… Read more »
Teva Wins Approval for Generic EpiPen Auto-Injector, Launch Being Planned
In the midst of an auto-injector shortage, the FDA approved a new U.S. competitor to the generic auto-injector options in… Read more »